UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-22572

Destra Multi-Alternative Fund

(Exact name of registrant as specified in charter)

443 N Willson Avenue

Bozeman, MT 59715

(Address of principal executive offices) (Zip code)

Robert A. Watson

C/O Destra Capital Advisors LLC

443 N Willson Avenue

Bozeman, MT 59715

(Name and address of agent for service)

Registrant’s telephone number, including area code: (312) 843-6161

Date of fiscal year end: March 31

Date of reporting period: September 30, 2024

Item 1. Reports to Stockholders.

(a)

Destra Multi-Alternative Fund

Semi-Annual Report

September 30, 2024

(Unaudited)

Table of Contents

Risk Disclosure		3
Schedule of Investments		4
Statement of Assets and Liabilities		12
Statement of Operations		13
Statements of Changes in Net Assets		14
Statement of Cash Flows		15
Financial Highlights		16
Notes to Financial Statements		18
Additional Information		29
Fund Information		30

Destra Multi-Alternative Fund

Risk Disclosure

As of September 30, 2024 (unaudited)

This document may contain forward-looking statements representing Destra Capital Advisors LLC’s (“Destra”), the portfolio managers’ or sub-adviser’s beliefs concerning future operations, strategies, financial results or other developments. Investors are cautioned that such forward-looking statements involve risks and uncertainties. Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond Destra’s, the portfolio managers’ or sub-adviser’s control or are subject to change, actual results could be materially different. There is no guarantee that such forward-looking statements will come to pass.

Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. The prospectus contains this and other information relevant to an investment in the Fund. Please read the prospectus carefully before investing. You may obtain a prospectus through the broker dealer, where you hold your shares or by visiting the Fund’s webpage at www.destracapital.com/DMA or by calling Destra at 877-855-3434 or the Fund’s Transfer Agent, Equiniti Trust Company, LLC at 800-591-8238.

Destra Multi-Alternative Fund

Schedule of Investments

As of September 30, 2024 (unaudited)

Shares/ Contracts/ Principal		Security	Value
		COMMON STOCKS – 16.1%
		AEROSPACE/DEFENSE – 0.5%
	1,000	Northrop Grumman Corp.	$	528,070

		BANKS – 0.6%
	997	Goldman Sachs Group, Inc.		493,625
	849	PNC Financial Services Group, Inc.		156,937
				650,562
		BIOTECHNOLOGY – 0.5%
	8,334	Corteva, Inc.		489,956

		CHEMICALS – 0.5%
	2,068	Ecolab, Inc.		528,022

		COMMERCIAL SERVICES – 0.5%
	6,932	Affirm Holdings, Inc.⁽¹⁾		282,964
	3,124	Square, Inc. - Class A⁽¹⁾		209,714
				492,678
		COMPUTERS – 0.7%
	6,800	Cognizant Technology Solutions Corp., Class A		524,824
	6,253	Rubrik, Inc., Class A⁽¹⁾		201,034
				725,858
		DIVERSIFIED FINANCIAL SERVICES – 0.5%
	2,100	American Express Co.		569,520

		ELECTRIC – 0.6%
	7,227	NextEra Energy, Inc.		610,898

		ENTERTAINMENT – 0.2%
	5,319	DraftKings, Inc. – Class A⁽¹⁾		208,505

		FOOD SERVICE – 0.5%
	1,600	McDonald’s Corp.		487,216

		HEALTHCARE-PRODUCTS – 0.2%
	1,826	Natera, Inc.⁽¹⁾		231,811

		HEALTHCARE-SERVICES – 0.4%
	900	Elevance Health, Inc.		468,000

		INSURANCE – 0.5%
	6,022	MetLife, Inc.		496,694

		INTERNET – 4.7%
	10,814	Amazon.com, Inc.⁽¹⁾⁽²⁾*		2,014,973
	4,100	Meta Platforms, Inc. – Class A⁽²⁾*		2,347,004
	3,128	Shopify, Inc.⁽¹⁾		250,678
	1,277	Wix.Com Ltd.⁽¹⁾		213,476
				4,826,131

Shares/ Contracts/ Principal		Security	Value
		COMMON STOCKS (continued)
		MACHINERY-DIVERSIFIED – 0.4%
	900	Deere & Co.	$	375,597

		MISCELLANEOUS MANUFACTURING – 0.1%
	240	Parker-Hannifin Corp.		151,637

		OIL & GAS – 0.4%
	3,200	EOG Resources, Inc.		393,376

		PHARMACEUTICALS – 0.8%
	1,089	AbbVie, Inc.		215,056
	5,200	Cardinal Health, Inc.		574,704
				789,760
		RETAIL – 0.1%
	1,302	TJX Companies, Inc.		153,037

		SEMICONDUCTORS – 0.2%
	701	Analog Devices, Inc.		161,349

		SOFTWARE – 1.6%
	1,002	Duolingo, Inc.⁽¹⁾		282,584
	2,000	Microsoft Corp.		860,600
	8,240	Palantir Technologies, Inc. – Class A⁽¹⁾		306,528
	1,502	Snowflake, Inc. – Class A⁽¹⁾		172,520
				1,622,232
		TELECOMMUNICATIONS – 1.1%
	9,006	Cisco Systems, Inc.		479,299
	15,000	Corning, Inc.		677,250
				1,156,549
		TRANSPORTATION – 0.5%
	2,193	Union Pacific Corp.		540,531

		TOTAL COMMON STOCKS (Cost $15,216,931)		16,657,989

		EXCHANGE-TRADED FUNDS – 3.4%
	50,167	Janus Henderson AAA CLO ETF		2,552,497
	20,500	Janus Henderson B-BBB CLO ETF		1,003,475
		TOTAL EXCHANGE-TRADED FUNDS (Cost $3,561,514)		3,555,972

		MEDIUM TERM NOTES – 3.9%
		DIVERSIFIED FINANCIAL SERVICES – 3.9%
	2,000,000	Citigroup Global Markets Holdings, Inc., 0.0%, 06/24/27^(1)(3)(4)		2,000,000
	2,000,000	Goldman Sachs Finance Corp., 0.0%, 06/24/27^(1)(3)(4)		2,000,000
				4,000,000
		TOTAL MEDIUM TERM NOTES (Cost $4,000,000)		4,000,000

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Schedule of Investments (continued)

As of September 30, 2024 (unaudited)

Shares/ Contracts/ Principal		Security	Value
		PRIVATE COMPANIES – 20.6%
	744,880	Always AI, Inc., (254,113 Series A-1, 490,767 Series B) Preferred Stock^(1)(3)(4)	$	3,979,042
	2,000,000	Always AI, Inc., Convertible Debt, 8.0%, 09/29/25⁽³⁾⁽⁴⁾		2,000,000
	600,000	Always AI, Inc., Convertible Debt, 8.0%, 05/31/26⁽³⁾⁽⁴⁾		600,000
	179,641	Clear Street Group, Inc., Series B-1 Preferred Stock^(1)(3)(4)		1,500,002
	332,938	Copia Wealth Studios, Common Shares^(1)(3)(4)		938,386
	1,064,396	Copia Wealth Studios, Preferred Shares^(1)(3)(4)		3,000,000
	23,723	Eat Just, Inc., Series F Common Stock^(1)(3)(4)		472,562
	56,331	GOSITE, Inc., Convertible Debt, 10.0%, 04/19/25⁽³⁾⁽⁴⁾		56,331
	542,467	GOSITE, Inc., Series A-1 Preferred Stock^(1)(3)(4)		2,738,373
	750,000	Iridia, Inc., Convertible Debt, 8.0%, 06/20/25⁽³⁾⁽⁴⁾		750,000
	497,216	Iridia, Inc., Series A-3 Preferred Stock^(1)(3)(4)		1,299,458
	2,387,937	Nurture Life, Inc., Series B Preferred Stock^(1)(3)(4)		3,946,543
		TOTAL PRIVATE COMPANIES (Cost $16,529,514)		21,280,697

		PURCHASED OPTIONS CONTRACTS* – 1.9%
		CALL OPTIONS – 1.9%
	50	AbbVie, Inc. Exercise Price: $220, Notional Amount: $1,100,000, Expiration Date: 10/18/2024⁽¹⁾		500
	9	Adobe, Inc. Exercise Price: $615, Notional Amount: $553,500, Expiration Date: 08/15/2025⁽¹⁾		26,640
	6	Adobe, Inc. Exercise Price: $670, Notional Amount: $402,000, Expiration Date: 08/15/2025⁽¹⁾		10,575
	22	Advanced Micro Devices, Inc. Exercise Price: $185, Notional Amount: $407,000, Expiration Date: 12/20/2024⁽¹⁾		16,940
	17	Advanced Micro Devices, Inc. Exercise Price: $175, Notional Amount: $297,500, Expiration Date: 03/21/2025⁽¹⁾		30,719
	15	Advanced Micro Devices, Inc. Exercise Price: $165, Notional Amount: $247,500, Expiration Date: 06/20/2025⁽¹⁾		41,040

Shares/ Contracts/ Principal		Security	Value
		PURCHASED OPTIONS CONTRACTS (continued)
		CALL OPTIONS (continued)
	24	Advanced Micro Devices, Inc. Exercise Price: $195, Notional Amount: $468,000, Expiration Date: 09/19/2025⁽¹⁾	$	49,800
	21	AeroVironment, Inc. Exercise Price: $220, Notional Amount: $462,000, Expiration Date: 03/21/2025⁽¹⁾		40,425
	13	AeroVironment, Inc. Exercise Price: $240, Notional Amount: $312,000, Expiration Date: 01/16/2026⁽¹⁾		39,325
	100	Affirm Holdings, Inc. Exercise Price: $55, Notional Amount: $550,000, Expiration Date: 03/21/2025⁽¹⁾		35,300
	9	Amazon.com, Inc. Exercise Price: $195, Notional Amount: $175,500, Expiration Date: 01/16/2026⁽¹⁾		24,084
	40	Analog Devices, Inc. Exercise Price: $250, Notional Amount: $1,000,000, Expiration Date: 10/18/2024⁽¹⁾		1,800
	6	ASML Holding NV Exercise Price: $1,120, Notional Amount: $672,000, Expiration Date: 06/20/2025⁽¹⁾		19,830
	7	Axon Enterprise, Inc. Exercise Price: $410, Notional Amount: $287,000, Expiration Date: 06/20/2025⁽¹⁾		33,915
	11	Axon Enterprise, Inc. Exercise Price: $440, Notional Amount: $484,000, Expiration Date: 06/20/2025⁽¹⁾		39,490
	37	Block, Inc. Exercise Price: $75, Notional Amount: $277,500, Expiration Date: 01/17/2025⁽¹⁾		15,355
	42	Block, Inc. Exercise Price: $78, Notional Amount: $325,500, Expiration Date: 06/20/2025⁽¹⁾		33,180
	55	Broadcom, Inc. Exercise Price: $188, Notional Amount: $1,034,000, Expiration Date: 10/18/2024⁽¹⁾		6,050
	90	Cisco Systems, Inc. Exercise Price: $53, Notional Amount: $472,500, Expiration Date: 10/18/2024⁽¹⁾		9,090
	68	Cognizant Technology Solutions Corp. Exercise Price: $85, Notional Amount: $578,000, Expiration Date: 10/18/2024⁽¹⁾		—

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Schedule of Investments (continued)

As of September 30, 2024 (unaudited)

Shares/ Contracts/ Principal		Security	Value
		PURCHASED OPTIONS CONTRACTS (continued)
		CALL OPTIONS (continued)
	150	Corning, Inc. Exercise Price: $48, Notional Amount: $720,000, Expiration Date: 10/18/2024⁽¹⁾	$	1,500
	8	Crowdstrike Holdings, Inc. Exercise Price: $390, Notional Amount: $312,000, Expiration Date: 12/20/2024⁽¹⁾		1,560
	10	Crowdstrike Holdings, Inc. Exercise Price: $460, Notional Amount: $460,000, Expiration Date: 01/17/2025⁽¹⁾		1,005
	6	Crowdstrike Holdings, Inc. Exercise Price: $270, Notional Amount: $162,000, Expiration Date: 06/20/2025⁽¹⁾		30,816
	11	Crowdstrike Holdings, Inc. Exercise Price: $340, Notional Amount: $374,000, Expiration Date: 06/20/2025⁽¹⁾		25,823
	65	DraftKings, Inc. Exercise Price: $50, Notional Amount: $325,000, Expiration Date: 01/17/2025⁽¹⁾		7,280
	100	DraftKings, Inc. Exercise Price: $60, Notional Amount: $600,000, Expiration Date: 03/21/2025⁽¹⁾		8,700
	38	DraftKings, Inc. Exercise Price: $40, Notional Amount: $152,000, Expiration Date: 06/20/2025⁽¹⁾		26,790
	7	Eli Lilly And Co Exercise Price: $1,000, Notional Amount: $700,000, Expiration Date: 06/20/2025⁽¹⁾		43,750
	5	Eli Lilly And Co Exercise Price: $1,040, Notional Amount: $520,000, Expiration Date: 01/16/2026⁽¹⁾		41,725
	10	Goldman Sachs Group, Inc. Exercise Price: $540, Notional Amount: $540,000, Expiration Date: 10/18/2024⁽¹⁾		1,020
	48	Guidewire Software, Inc. Exercise Price: $190, Notional Amount: $912,000, Expiration Date: 04/17/2025⁽¹⁾		77,760
	1	Guidewire Software, Inc. Exercise Price: $185, Notional Amount: $18,500, Expiration Date: 04/17/2025⁽¹⁾		1,820
	13	HubSpot, Inc. Exercise Price: $680, Notional Amount: $884,000, Expiration Date: 01/17/2025⁽¹⁾		6,305

Shares/ Contracts/ Principal		Security	Value
		PURCHASED OPTIONS CONTRACTS (continued)
		CALL OPTIONS (continued)
	45	Marathon Petroleum Corp. Exercise Price: $190, Notional Amount: $855,000, Expiration Date: 10/18/2024⁽¹⁾	$	1,013
	42	Marvell Technology, Inc. Exercise Price: $85, Notional Amount: $357,000, Expiration Date: 03/21/2025⁽¹⁾		20,160
	38	Marvell Technology, Inc. Exercise Price: $90, Notional Amount: $342,000, Expiration Date: 06/20/2025⁽¹⁾		22,705
	65	Marvell Technology, Inc. Exercise Price: $83, Notional Amount: $536,250, Expiration Date: 06/20/2025⁽¹⁾		49,725
	10	Meta Platforms, Inc. Exercise Price: $620, Notional Amount: $620,000, Expiration Date: 03/21/2025⁽¹⁾		41,550
	12	Meta Platforms, Inc. Exercise Price: $590, Notional Amount: $708,000, Expiration Date: 06/20/2025⁽¹⁾		85,272
	6	Meta Platforms, Inc. Exercise Price: $600, Notional Amount: $360,000, Expiration Date: 06/20/2025⁽¹⁾		39,678
	20	Microsoft Corp. Exercise Price: $485, Notional Amount: $970,000, Expiration Date: 10/18/2024⁽¹⁾		80
	10	Mp Materials Corp. Exercise Price: $45, Notional Amount: $45,000, Expiration Date: 01/17/2025⁽¹⁾		—
	30	Mp Materials Corp. Exercise Price: $50, Notional Amount: $150,000, Expiration Date: 01/17/2025⁽¹⁾		—
	5	Netflix, Inc. Exercise Price: $740, Notional Amount: $370,000, Expiration Date: 12/20/2024⁽¹⁾		16,550
	4	Netflix, Inc. Exercise Price: $720, Notional Amount: $288,000, Expiration Date: 06/20/2025⁽¹⁾		34,800
	5	Netflix, Inc. Exercise Price: $780, Notional Amount: $390,000, Expiration Date: 06/20/2025⁽¹⁾		31,487
	72	NextEra Energy, Inc. Exercise Price: $90, Notional Amount: $648,000, Expiration Date: 10/18/2024⁽¹⁾		2,160

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Schedule of Investments (continued)

As of September 30, 2024 (unaudited)

Shares/ Contracts/ Principal		Security	Value
		PURCHASED OPTIONS CONTRACTS (continued)
		CALL OPTIONS (continued)
	47	Nike, Inc. Exercise Price: $93, Notional Amount: $434,750, Expiration Date: 10/18/2024⁽¹⁾	$	8,601
	10	Northrop Grumman Corp. Exercise Price: $560, Notional Amount: $560,000, Expiration Date: 11/15/2024⁽¹⁾		6,850
	18	NVIDIA Corp. Exercise Price: $146, Notional Amount: $262,800, Expiration Date: 01/17/2025⁽¹⁾		9,720
	16	NVIDIA Corp. Exercise Price: $158, Notional Amount: $252,800, Expiration Date: 01/17/2025⁽¹⁾		5,632
	20	NVIDIA Corp. Exercise Price: $153, Notional Amount: $306,000, Expiration Date: 03/21/2025⁽¹⁾		15,100
	40	NVIDIA Corp. Exercise Price: $145, Notional Amount: $580,000, Expiration Date: 10/18/2024⁽¹⁾		880
	60	NVIDIA Corp. Exercise Price: $155, Notional Amount: $930,000, Expiration Date: 11/15/2024⁽¹⁾		4,860
	15	NVIDIA Corp. Exercise Price: $152, Notional Amount: $228,000, Expiration Date: 10/18/2024⁽¹⁾		135
	40	NVIDIA Corp. Exercise Price: $138, Notional Amount: $552,000, Expiration Date: 03/21/2025⁽¹⁾		45,160
	10	Palo Alto Networks, Inc. Exercise Price: $380, Notional Amount: $380,000, Expiration Date: 03/21/2025⁽¹⁾		20,500
	5	Palo Alto Networks, Inc. Exercise Price: $350, Notional Amount: $175,000, Expiration Date: 06/20/2025⁽¹⁾		21,925
	5	Palo Alto Networks, Inc. Exercise Price: $360, Notional Amount: $180,000, Expiration Date: 06/20/2025⁽¹⁾		19,050
	44	PayPal Holdings, Inc. Exercise Price: $80, Notional Amount: $352,000, Expiration Date: 04/17/2025⁽¹⁾		36,300
	42	PDD Holdings, Inc. Exercise Price: $180, Notional Amount: $756,000, Expiration Date: 01/17/2025⁽¹⁾		15,120

Shares/ Contracts/ Principal		Security	Value
		PURCHASED OPTIONS CONTRACTS (continued)
		CALL OPTIONS (continued)
	95	Pinterest, Inc. Exercise Price: $45, Notional Amount: $427,500, Expiration Date: 10/18/2024⁽¹⁾	$	190
	21	Pinterest, Inc. Exercise Price: $41, Notional Amount: $86,100, Expiration Date: 11/15/2024⁽¹⁾		966
	64	Pinterest, Inc. Exercise Price: $55, Notional Amount: $352,000, Expiration Date: 01/17/2025⁽¹⁾		960
	60	Pinterest, Inc. Exercise Price: $55, Notional Amount: $330,000, Expiration Date: 03/21/2025⁽¹⁾		1,800
	193	Pinterest, Inc. Exercise Price: $35, Notional Amount: $675,500, Expiration Date: 06/20/2025⁽¹⁾		82,507
	250	ProShares Bitcoin ETF Exercise Price: $27, Notional Amount: $675,000, Expiration Date: 12/20/2024⁽¹⁾		6,500
	250	ProShares Bitcoin ETF Exercise Price: $24, Notional Amount: $600,000, Expiration Date: 01/17/2025⁽¹⁾		14,750
	110	Rubrik, Inc. Exercise Price: $45, Notional Amount: $495,000, Expiration Date: 01/17/2025⁽¹⁾		12,100
	31	Rubrik, Inc. Exercise Price: $35, Notional Amount: $108,500, Expiration Date: 01/17/2025⁽¹⁾		9,300
	123	Samsara, Inc. Exercise Price: $60, Notional Amount: $738,000, Expiration Date: 06/20/2025⁽¹⁾		59,040
	68	Shopify, Inc. Exercise Price: $90, Notional Amount: $612,000, Expiration Date: 06/20/2025⁽¹⁾		65,620
	10	Snowflake, Inc. Exercise Price: $230, Notional Amount: $230,000, Expiration Date: 01/17/2025⁽¹⁾		150
	34	Snowflake, Inc. Exercise Price: $160, Notional Amount: $544,000, Expiration Date: 03/21/2025⁽¹⁾		15,300
	10	Snowflake, Inc. Exercise Price: $135, Notional Amount: $135,000, Expiration Date: 03/21/2025⁽¹⁾		9,875

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Schedule of Investments (continued)

As of September 30, 2024 (unaudited)

Shares/ Contracts/ Principal		Security	Value
		PURCHASED OPTIONS CONTRACTS (continued)
		CALL OPTIONS (continued)
	11	Snowflake, Inc. Exercise Price: $140, Notional Amount: $154,000, Expiration Date: 03/21/2025⁽¹⁾	$	8,965
	12	Tesla, Inc. Exercise Price: $330, Notional Amount: $396,000, Expiration Date: 03/21/2025⁽¹⁾		25,620
	55	TJX Companies, Inc. Exercise Price: $130, Notional Amount: $715,000, Expiration Date: 10/18/2024⁽¹⁾		—
	28	Trade Desk, Inc. Exercise Price: $120, Notional Amount: $336,000, Expiration Date: 01/17/2025⁽¹⁾		16,268
	22	Trade Desk, Inc. Exercise Price: $115, Notional Amount: $253,000, Expiration Date: 06/20/2025⁽¹⁾		33,495
	40	Uber Technologies, Inc. Exercise Price: $95, Notional Amount: $380,000, Expiration Date: 12/20/2024⁽¹⁾		3,080
	40	Uber Technologies, Inc. Exercise Price: $78, Notional Amount: $310,000, Expiration Date: 01/17/2025⁽¹⁾		21,680
	50	Uber Technologies, Inc. Exercise Price: $83, Notional Amount: $412,500, Expiration Date: 01/17/2025⁽¹⁾		17,750
	100	UiPath, Inc. Exercise Price: $27, Notional Amount: $270,000, Expiration Date: 11/15/2024⁽¹⁾		—
	100	UiPath, Inc. Exercise Price: $25, Notional Amount: $250,000, Expiration Date: 01/17/2025⁽¹⁾		800
	12	Ulta Beauty, Inc. Exercise Price: $470, Notional Amount: $564,000, Expiration Date: 03/21/2025⁽¹⁾		15,960
	7	Ulta Beauty, Inc. Exercise Price: $430, Notional Amount: $301,000, Expiration Date: 06/20/2025⁽¹⁾		23,205
	8	Ulta Beauty, Inc. Exercise Price: $450, Notional Amount: $360,000, Expiration Date: 06/20/2025⁽¹⁾		21,144
	100	Utilities Select Sector SPDR Fund Exercise Price: $86, Notional Amount: $860,000, Expiration Date: 06/20/2025⁽¹⁾		26,350

Shares/ Contracts/ Principal		Security	Value
		PURCHASED OPTIONS CONTRACTS (continued)
		CALL OPTIONS (continued)
	80	Vanguard Small-Cap Value Index Fund ETF Exercise Price: $210, Notional Amount: $1,680,000, Expiration Date: 03/21/2025⁽¹⁾	$	55,600
	13	Veeva Systems, Inc. Exercise Price: $250, Notional Amount: $325,000, Expiration Date: 01/17/2025⁽¹⁾		3,510
	9	Veeva Systems, Inc. Exercise Price: $240, Notional Amount: $216,000, Expiration Date: 01/17/2025⁽¹⁾		3,960
	10	Vertex Pharmaceuticals Incorporated Exercise Price: $580, Notional Amount: $580,000, Expiration Date: 06/20/2025⁽¹⁾		12,450
	8	Vertex Pharmaceuticals Incorporated Exercise Price: $540, Notional Amount: $432,000, Expiration Date: 06/20/2025⁽¹⁾		17,240
	17	Wix.Com Ltd. Exercise Price: $200, Notional Amount: $340,000, Expiration Date: 03/21/2025⁽¹⁾		15,385
	20	Zscaler, Inc. Exercise Price: $190, Notional Amount: $380,000, Expiration Date: 06/20/2025⁽¹⁾		39,100
		TOTAL CALL OPTIONS		1,945,545

		TOTAL PURCHASED OPTIONS CONTRACTS (Cost $2,327,774)		1,945,545

		CONTINGENT VALUE RIGHTS – 0.2%
		PHARMACEUTICALS – 0.0%
	142,000	Bristol-Myers Squibb Co., 03/31/21⁽¹⁾⁽³⁾		—

		REAL ESTATE – 0.2%
	456,540	Hospitality Investors Trust, Inc., 06/29/26^(1)(3)(4)*		241,226
	579,536	Ready Capital Corp., 03/16/25^(1)(3)(4)		—
				241,226
		TOTAL CONTINGENT VALUE RIGHTS (Cost $9,395,583)		241,226

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Schedule of Investments (continued)

As of September 30, 2024 (unaudited)

Shares/ Contracts/ Principal		Security	Value
		WARRANTS – 1.0%
		FOOD – 1.0%
	878,570	Nurture Life, Inc., 12/23/32^(1)(3)(4)	$	992,784

		SOFTWARE – 0.0%
	1	Always AI, Inc., 09/28/33^(1)(3)(4)		—
		TOTAL WARRANTS (Cost $—)		992,784

		REAL ESTATE INVESTMENT TRUSTS – 24.4%
		LISTED REAL ESTATE INVESTMENT TRUSTS – 5.4%
	2,645	American Tower Corp.		615,121
	3,838	Digital Realty Trust, Inc.		621,104
	700	Equinix, Inc.		621,341
	17,573	Invitation Homes, Inc.		619,624
	9,175	Prologis, Inc.		1,158,619
	12,131	Rexford Industrial Realty, Inc.		610,311
	19,000	VICI Properties, Inc.		632,890
	5,000	Welltower, Inc.		640,150
		TOTAL LISTED REAL ESTATE INVESTMENT TRUSTS		5,519,160

		NON-LISTED REAL ESTATE INVESTMENT TRUSTS – 7.8%
	344,812	Healthcare Trust, Inc., Common Stock⁽³⁾⁽⁴⁾*		4,937,522
	1,061,081	NorthStar Healthcare Income, Inc., Common Stock^(1)(3)(4)*		3,129,503
		TOTAL NON-LISTED REAL ESTATE INVESTMENT TRUSTS		8,067,025

		PRIVATE REAL ESTATE INVESTMENT TRUSTS – 11.2%
	715,000	Aventine Property Group, Inc., Common Stock⁽³⁾⁽⁴⁾		6,780,988
	715,000	Treehouse Real Estate Investment Trust, Inc., Common Stock^(1)(3)(4)		4,802,012
		TOTAL PRIVATE REAL ESTATE INVESTMENT TRUSTS		11,583,000

		TOTAL REAL ESTATE INVESTMENT TRUSTS (Cost $31,407,940)		25,169,185

		ALTERNATIVE INVESTMENT FUNDS – 41.5%
	250	Arboretum Core Asset Fund LP⁽⁴⁾⁽⁵⁾		2,344,110
	—	Canyon CLO Fund II LP^(3)(4)(6)		7,911,928
	—	Canyon CLO Fund III (Cayman) Ltd.^(3)(4)(6)		14,522,023
	2,959	Clarion Lion Industrial Trust⁽⁴⁾⁽⁵⁾		11,087,156
	—	Ovation Alternative Income Fund^(4)(5)(6)		484,522
	160	Preservation REIT 1, Inc.^(1)(4)(5)		6,434,170
		TOTAL ALTERNATIVE INVESTMENT FUNDS (Cost $29,100,703)		42,783,909

Shares/ Contracts/ Principal			Security	Value
			SHORT-TERM INVESTMENTS – 6.9%
			MONEY MARKET FUND – 6.9%
	7,073,430		Fidelity Investments Money Market Funds - Government Portfolio, Class I, 4.83%⁽²⁾⁽⁷⁾	$	7,073,430
			TOTAL SHORT-TERM INVESTMENTS (Cost $7,073,430)		7,073,430

			TOTAL INVESTMENTS – 119.9% (Cost $118,613,389)		123,700,737
			Liabilities in Excess of Other Assets – (19.9)%		(20,513,321	)
			TOTAL NET ASSETS – 100.0%		103,187,416

			WRITTEN OPTIONS CONTRACTS* – (0.2)%
			PUT OPTIONS – (0.1)%
	(40	)	Marathon Petroleum Corp. Exercise Price: $160, Notional Amount: $(640,000), Expiration Date: 10/18/2024		(12,600	)
	(250	)	ProShares Bitcoin ETF Exercise Price: $15, Notional Amount: $(375,000), Expiration Date: 01/17/2025		(50,250	)
			TOTAL PUT OPTIONS		(62,850	)

			CALL OPTIONS – (0.1)%
	(45	)	Cisco Systems, Inc. Exercise Price: $48, Notional Amount: $(213,750), Expiration Date: 10/18/2024		(25,425	)
	(68	)	Cognizant Technology Solutions Corp. Exercise Price: $78, Notional Amount: $(527,000), Expiration Date: 10/18/2024		(7,480	)
	(150	)	Corning, Inc. Exercise Price: $44, Notional Amount: $(660,000), Expiration Date: 10/18/2024		(24,300	)
	(5)		Goldman Sachs Group, Inc. Exercise Price: $490, Notional Amount: $(245,000), Expiration Date: 10/18/2024		(8,190	)
	(20	)	Microsoft Corp. Exercise Price: $440, Notional Amount: $(880,000), Expiration Date: 10/18/2024		(7,460	)
	(72	)	NextEra Energy, Inc. Exercise Price: $83, Notional Amount: $(594,000), Expiration Date: 10/18/2024		(23,544	)
	(22	)	Nike, Inc. Exercise Price: $78, Notional Amount: $(170,500), Expiration Date: 11/15/2024		(26,444	)

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Schedule of Investments (continued)

As of September 30, 2024 (unaudited)

Shares/ Contracts/ Principal			Security	Value
			WRITTEN OPTIONS CONTRACTS* (continued)
			Call OPTIONS (continued)
	(10	)	Northrop Grumman Corp. Exercise Price: $520, Notional Amount: $(520,000), Expiration Date: 11/15/2024	$	(20,900	)
			TOTAL CALL OPTIONS		(143,743	)

			TOTAL WRITTEN OPTIONS CONTRACTS (Proceeds $(140,997))		(206,593	)

			EXCHANGE-TRADED FUND SOLD SHORT – (0.7)%
	(9,800	)	ProShares UltraPro QQQ		(710,402	)
			TOTAL EXCHANGE-TRADED FUND SOLD SHORT (Proceeds $(167,745))		(710,402	)

			TOTAL SHORT SECURITIES (Proceeds $(308,742))	$	(916,995	)

	⁽¹⁾	Non-income producing security.
	⁽²⁾	All or a portion of this security is segregated as collateral for securities sold short.
	⁽³⁾	Fair valued using significant unobservable inputs (See Note 2).
	⁽⁴⁾	Restricted investment as to resale (See Note 2).
	⁽⁵⁾	Investments in Alternative Investment Funds are valued using net asset value as a practical expedient. See Note 2 for respective investment strategies, unfunded commitments and redemptive restrictions.
	⁽⁶⁾	Alternative investment fund does not issue shares.
	⁽⁷⁾	The rate is the annualized seven-day yield as of September 30, 2024.
	*	All securities are pledged as collateral except for securities identified with a * superscript.

ETF — Exchange-Traded Fund

LP — Limited Partnership

REIT — Real Estate Investment Trusts

SPDR — Standard & Poor’s Depository Receipts

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Schedule of Investments (continued)

As of September 30, 2024 (unaudited)

	Percent of
	Net Assets
Alternative Investment Funds		41.5	%
Real Estate Investment Trusts
Private Real Estate Investment Trusts		11.2	%
Non-Listed Real Estate Investment Trusts		7.8	%
Listed Real Estate Investment Trusts		5.4	%
Private Companies		20.6	%
Common Stocks
Internet		4.7	%
Software		1.6	%
Telecommunications		1.1	%
Pharmaceuticals		0.8	%
Computers		0.7	%
Banks		0.6	%
Electric		0.6	%
Diversified Financial Services		0.5	%
Transportation		0.5	%
Aerospace/Defense		0.5	%
Chemicals		0.5	%
Food Service		0.5	%
Insurance		0.5	%
Commercial Services		0.5	%
Biotechnology		0.5	%
Machinery-Diversified		0.4	%
Oil & Gas		0.4	%
Healthcare-Services		0.4	%
Semiconductors		0.2	%
Healthcare-Products		0.2	%
Entertainment		0.2	%
Miscellaneous Manufacturing		0.1	%
Retail		0.1	%
Exchange-Traded Funds		3.4	%
Purchased Options Contracts		1.9	%
Warrants		1.0	%
Contingent Value Rights
Real Estate		0.2	%
Pharmaceuticals		0.0	%
Medium Term Notes
Diversified Financial Services		3.9	%
Short-Term Investments		6.9	%
Liabilities in Excess of Other Assets		(19.9	)%
Net Assets		100.0	%
Written Options Contracts		(0.2	)%
Exchange-Traded Fund Sold Short		(0.7	)%

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Statement of Assets and Liabilities

As of September 30, 2024 (unaudited)

Assets:
Investments, at value (cost $116,285,615)	$	121,755,192
Purchased options contracts, at value (cost $2,327,774)		1,945,545
Receivables:
Interest		220,143
Dividends		98,102
Investments sold		2,381
Prepaid expenses		10,208
Other assets		628
Total assets		124,032,199

Liabilities:
Credit facility (see note 6)		11,999,483
Due to broker		7,559,969
Securities sold short, at value (proceeds $167,745)		710,402
Written options contracts, at value (premium received $140,997)		206,593

Payables:
Management fee (see note 3)		108,312
Investments purchased		99,587
Professional fees		78,465
Accounting and administrative fees		32,548
Interest payable		26,749
Transfer agent fees and expenses		4,211
Custody fees		2,602
Chief financial officer fees		2,599
Trustee fees		570
Chief compliance officer fees		188
Accrued other expenses		12,505
Total liabilities		20,844,783
Commitments and contingencies (see note 2)

Net assets	$	103,187,416

Net assets consist of:
Paid-in capital (unlimited shares authorized at $0.001 par value common stock)	$	98,100,278
Total distributable earnings		5,087,138
Net assets	$	103,187,416

Common shares outstanding		8,963,239

Net asset value per common share	$	11.51

Market price per common share	$	8.67

Market price (discount) to net asset value per common share		(24.67	)%

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Statement of Operations

For the six months ended September 30, 2024 (unaudited)

Investment income:
Distributions from alternative investment funds	$	2,523,801
Dividend income		183,853
Interest income		383,004
Total investment income		3,090,658

Expenses:
Interest expense		1,154,595
Management fee (see note 3)		786,794
Professional fees		163,309
Accounting and administrative fees		103,293
Service provider fees		58,281
Chief financial officer fees (see note 8)		18,557
Trustee fees (see note 8)		17,013
Shareholder reporting fees		14,256
Transfer agent fees and expenses		14,255
Registration fees		12,534
Dividends on securities sold short		11,183
Chief compliance officer fees (see note 8)		10,826
Custody fees		9,722
Insurance expense		7,667
Other expenses		7,574
Total expenses		2,389,859
Service provider fees deferred and repaid by adviser (see note 3)		(58,281	)
Expenses waived by adviser (see note 3)		(109,060	)
Net expenses		2,222,518
Net investment income		868,140

Net realized and unrealized gain (loss):
Net realized gain (loss) on:
Investments		258,372
Purchased options contracts		441,004
Written options contracts		(79,856	)
Securities sold short		(1,293,912	)
Total net realized loss		(674,392	)

Net change in unrealized appreciation (depreciation) on:
Investments		2,181,068
Purchased options contracts		(191,399	)
Written options contracts		(11,862	)
Securities sold short		948,570
Total net change in unrealized appreciation		2,926,377
Net realized and unrealized gain		2,251,985
Net increase in net assets resulting from operations	$	3,120,125

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Statements of Changes in Net Assets

	Six Months Ended September 30, 2024 (Unaudited)			Year Ended March 31, 2024
Increase in net assets resulting from operations:
Net investment income (loss)	$	868,140		$	(628,204	)
Net realized gain (loss)		(674,392	)		3,425,081
Net change in unrealized appreciation		2,926,377			4,070,247
Net increase in net assets resulting from operations		3,120,125			6,867,124

Return of capital to shareholders:
Common Shares		—			(1,429,636	)
Total return of capital to shareholders		—			(1,429,636	)

Total increase in net assets		3,120,125			5,437,488

Net assets:
Beginning of period		100,067,291			94,629,803
End of period	$	103,187,416		$	100,067,291

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Statement of Cash Flows

For the six months ended September 30, 2024 (unaudited)

Cash flows from operating activities:
Net increase in net assets from operations	$	3,120,125
Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities:
Purchases of investments		(61,851,933	)
Proceeds from purchases of investments sold short		1,037,199
Proceeds from redemptions, sales, or other dispositions of investments		58,435,710
Sales of investments sold short		(3,066,452	)
Net realized (gain) loss on:
Investments		(258,372	)
Purchased options contracts		(441,004	)
Written options contracts		79,856
Securities sold short		1,293,912
Net change in unrealized (appreciation) depreciation on:
Investments		(2,181,068	)
Purchased options contracts		191,399
Written options contracts		11,862
Securities sold short		(948,570	)
Change in operating assets and liabilities:
Assets:
Investments sold		1,541,740
Interest		(111,558	)
Dividends		368,468
Prepaid expenses		42,835
Liabilities:
Investments purchased		67,684
Management fee		14,703
Custody fees		(2,244	)
Accounting and administration fees		(771	)
Professional fees		(53,410	)
Transfer agent fees and expenses		(2,500	)
Chief compliance officer fees		188
Chief financial officer fees		2,599
Trustee fees		570
Income tax payable		(89,391	)
Interest payable		26,749
Accrued other expenses		4,441
Net cash used in operating activities		(2,767,233	)

Cash flows from financing activities:
Due to broker		5,766,345
Repayments on credit facility		(3,000,000	)

Net cash provided by financing activities		2,766,345
Net change in cash and cash equivalents		(888	)
Cash and cash equivalents at beginning of period	$	888

Cash and cash equivalents at end of period	$	—

Supplemental disclosure of cash activity:
Interest paid on borrowings	$	1,154,595

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Financial Highlights

For a share of common stock outstanding throughout the periods indicated.**

	Net asset value, beginning of period		Net investment income (loss)⁽¹⁾			Net realized and unrealized gain (loss)			Total from investment operations			Distributions to shareholders from net investment income			Distributions to shareholders from net realized gain		Distributions to shareholders from return of capital			Total distributions			Net asset value, end of period		Total return⁽²⁾			Market price, end of period		Market price, return⁽³⁾			Gross expenses^(4),(5)			Net expenses^(4),(5),(6)			Net investment income (loss)^(5),(6),(7)			Net assets, end of period (in thousands)		Portfolio turnover rate
For the six months ended September 30,
2024 (unaudited)	$	11.16	$	0.10		$	0.25		$	0.35		$	—		$	—	$	—		$	—		$	11.51		3.14	%	$	8.67		10.87	%		4.69	%		4.36	%		1.70	%	$	103,187		25	%
Period ended March 31,
2024		10.56		(0.07	)		0.83			0.76			—			—		(0.16	)		(0.16	)		11.16		7.29			7.82		33.61			5.12			4.74			(0.65	)		100,067		23
2023		12.11		(0.03	)		(0.84	)		(0.87	)		(0.14	)		—		(0.54	)		(0.68	)		10.56		(7.37	)		6.02		(25.58	)		4.05			3.75			(0.26	)		96,350		12
2022*		11.77		0.02			0.38			0.40			(0.01	)		—		(0.05	)		(0.06	)		12.11		3.40			8.90		14.47			3.65	#		3.17	#		2.74	#		108,508		3
Period ended February 28,
2022		12.28		0.15			0.08			0.23			(0.09	)		—		(0.65	)		(0.74	)		11.77		1.79			7.83		(0.19	)^		3.38			2.74			1.24			105,522		28
2021		13.25		0.09			(0.34	)		(0.25	)		(0.07	)		—		(0.65	)		(0.72	)		12.28		(1.58	)		0		0			2.85			2.28			0.75			36,633		26
2020⁽⁸⁾		13.81		0.25			0.02			0.27			(0.08	)		—		(0.75	)		(0.83	)		13.25		1.90			0		0			2.98			2.57			1.78			35,208		42

*	For the period March 1, 2022 through March 31, 2022.
#	Annualized.
^	For the period January 13, 2022 through February 28, 2022.
⁽¹⁾	Based on average shares outstanding during the period.
⁽²⁾	Based on the net asset value as of period end. Assumes an investment at net asset value at the beginning of the period and reinvestment of all distributions during the period. The return would have been lower if certain expenses had not been waived or reimbursed by the investment adviser.
⁽³⁾	Market price return is computed based upon the Fund’s unrounded New York Stock Exchange market price per share and excludes the effects of brokerage commissions. Dividends and distributions are assumed, for purposes of these calculations, to be reinvested at prices obtained under the Fund’s dividend reinvestment plan.

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Financial Highlights (continued)

For a share of common stock outstanding throughout the periods indicated.**

⁽⁴⁾

Percentages shown include interest expense and dividends on securities sold short. Gross and net expense ratios, respectively, excluding interest expense and dividends on securities sold short are as follows:

	Gross Expenses⁽⁵⁾		Net Expenses^(5),(6)
For the six months ended September 30,
2024		2.40		2.07	%
Period ended March 31,
2024		2.50		2.12
2023		2.39		2.08
2022*		2.55		2.07	^#
Period ended February 28,
2022		2.44		1.81
2021		2.27		1.70
2020⁽⁸⁾		2.11		1.70

	*	For the period March 1, 2022 through March 31, 2022.
	^#	Annualized.
	⁽⁵⁾	Ratios do not include expenses of the underlying Alternative Investment Funds in which the Fund invests.
	⁽⁶⁾	The contractual fee and expense waiver is reflected in both the net expense and net investment income (loss) ratios (see Note 3).
	⁽⁷⁾	Recognition of net investment income by the Fund is affected by the timing of the declaration of dividends by the underlying Alternative Investment Funds in which the Fund invests. Ratios do not include net investment income of the Alternative Investment Funds in which the Fund Invests.
	⁽⁸⁾	Period ended February 29.

Credit Facility	For the six months ended September 30, 2024			For the year ended March 31, 2024			For the year ended March 31, 2023			For the period ended March 31, 2022*			For the year ended February 28, 2022			For the year ended February 28, 2021			For the year ended February 29, 2020
Senior securities, end of period (000’s)	$	12,000		$	15,000		$	15,000		$	15,000		$	15,000		$	14,300		$	29,300
Asset coverage, per $1,000 of senior security principal amount		9,599			7,671			7,309			8,234			8,035			9,080			5,433
Asset coverage ratio of senior securities		960	%		767	%		731	%		823	%		803	%		908	%		543	%

For the period March 1, 2022 through March 31, 2022.

The Fund’s shares began trading on the New York Stock Exchange (“NYSE”) on January 13, 2022 under NYSE ticker symbol “DMA.” To facilitate the listing of the Fund’s shares on the NYSE, the Fund redesignated its Class A, Class C and Class T shares as Class I shares and eliminated all share class designations. Consequently, the Fund’s shares are now referred to as shares of beneficial interest or common shares.

See accompanying Notes to Financial Statements.

Destra Multi-Alternative Fund

Notes to Financial Statements

September 30, 2024 (unaudited)

1. Organization

Destra Multi-Alternative Fund (“the Fund”) was organized as a Delaware statutory trust on June 3, 2011, is registered under the Investment Company Act of 1940, as amended, (the “1940 Act”), and is a non-diversified, exchange-listed closed-end management investment company.

The Fund changed its fiscal year end to March 31, effective March 1, 2022. The Fund’s shares began trading on the New York Stock Exchange (“NYSE”) on January 13, 2022 under NYSE ticker symbol “DMA.” To facilitate the listing of the Fund’s shares on the NYSE, effective January 5, 2022, the Fund redesignated its Class A, Class C and Class T shares as Class I shares and eliminated all share class designations. Consequently, the Fund’s shares are now referred to as shares of beneficial interest or common shares (the “Common Shares”).

The Fund’s investment adviser is Destra Capital Advisors LLC (the “Adviser”), the Fund’s sub-adviser is Validus Growth Investors, LLC, doing business as Validex Global Investing, (“Validex” or the “Sub-Adviser” and together with the Adviser are referred to herein as the “Advisers”). See Note 3 for additional information regarding Validex, as the Fund’s Sub-Adviser.

The investment objective of the Fund is to seek returns from capital appreciation and income with an emphasis on income generation. The Fund pursues its investment objective by investing primarily in the income-producing securities of real estate investment trusts (“REITs”) and alternative investment funds, as well as common stocks and structured notes, notes, bonds and asset-backed securities.

2. Summary of Significant Accounting Policies

The following is a summary of significant accounting policies followed by the Fund in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses for the period. Actual results could differ from those estimates. The Fund is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification Topic 946 “Financial Services — Investment Companies”.

Cash, Cash Equivalents and Restricted Cash — Cash and cash equivalents include U.S. dollar deposits at bank accounts at amounts which may exceed insured limits. The Fund is subject to risk to the extent that the institutions may be unable to fulfill their obligations. As of September 30, 2024, the Fund had no restricted cash.

Distributions to Shareholders — Prior to July 1, 2023, distributions from investment income were declared and paid monthly. Beginning with the start of the Fund’s second fiscal quarter on July 1, 2023 distributions from investment income will only be paid annually. Distributions from net realized capital gains, if any, are declared and paid annually. The character of income and gains to be distributed is determined in accordance with income tax regulations, which may differ from GAAP.

Security Valuation — The Fund records investments at fair value. Securities listed on an exchange are valued at the last reported sale price at the close of the regular trading session of the exchange on the business day the value is being determined, or in the case of securities listed on NASDAQ, at the NASDAQ Official Closing Price. In the absence of a sale, such securities shall be valued at the mean of the closing bid and asked prices on the day of valuation. Short-term investments that mature in 60 days or less may be valued at amortized cost, provided such valuations represent fair value.

When price quotations for certain securities are not readily available, or if the available quotations are not believed to be reflective of market value by the Adviser, those securities will be valued at “fair value” as determined in good faith by a Valuation Committee using the Valuation Procedures. There can be no assurance that the Fund could purchase or sell a portfolio security at the price used to calculate the Fund’s net asset value (“NAV”).

The Board of Trustees of the Fund (“the Board”) has approved valuation procedures for the Fund (the “Valuation Procedures”) which are used for determining the fair value of any Fund investments for which a market quotation is not readily available. The valuation of each of the Fund’s investments is performed in accordance with the principles found in Rule 2a-5 of the 1940 Act and in conjunction with FASB’s Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosures (“ASC 820-10”).The Board has designated the Adviser as the valuation designee of the Fund. As valuation designee, the Adviser performs the fair value determination relating to any and all Fund investments, subject to the conditions and oversight requirements described in the Valuation Procedures. In furtherance of its duties as valuation designee, the Adviser has formed a valuation committee (the “Valuation Committee”), to perform fair value determinations and oversee the day-to-day functions related to the fair valuation of the Fund’s investments. The Valuation Committee may consult with representatives from the Fund’s outside legal counsel or other third-party consultants in their discussions and deliberations.

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

Valuation Procedures may be used to value a substantial portion of the assets of the Fund. The Fund may use the fair value of a security to calculate its NAV when, for example, (1) a portfolio security is not traded in a public market or the principal market in which the security trades is closed, (2) trading in a portfolio security is suspended and not resumed prior to the normal market close, (3) a portfolio security is not traded in significant volume for a substantial period, or (4) the Adviser determines that the quotation or price for a portfolio security provided by a broker-dealer or independent pricing service is inaccurate. The “fair value” of securities may be difficult to determine and thus judgment plays a greater role in the valuation process. The fair valuation methodology may include or consider the following guidelines, as appropriate: (1) evaluation of all relevant factors, including but not limited to, pricing history, current market level, supply and demand of the respective security; (2) comparison to the values and current pricing of securities that have comparable characteristics; (3) knowledge of historical market information with respect to the security; (4) other factors relevant to the security which would include, but would not be limited to, duration, yield, fundamental analytical data, the Treasury yield curve, and credit quality. Calls with the management teams of these securities are completed to gain further insight that might not be as evident through the reading of published reports or filings.

Often, significant back-testing or historical data analysis is employed to gain increased, tangible perspective into ways to enhance the accuracy of either existing, or potentially new fair valuation approaches. This also ensures that recent enhancements or additional methodologies are leading to more accurate valuations.

Ongoing “logic checks” and evaluations of underlying portfolios are used to identify potential disconnects between current methodologies and expected results.

The values assigned to fair valued investments are based on available information and do not necessarily represent amounts that might ultimately be realized, since such amounts depend on future developments inherent in long-term investments. Changes in the fair valuation of portfolio securities may be less frequent and of greater magnitude than changes in the price of portfolio securities valued at their last sale price, by an independent pricing service, or based on market quotations. Imprecision in estimating fair value can also impact the amount of unrealized appreciation or depreciation recorded for a particular portfolio security and differences in the assumptions used could result in a different determination of fair value, and those differences could be material.

The Fund invests in some securities which are not traded and the Fair Valuation Committee has established a methodology for the fair valuation of each type of security. Non-listed REITs that are in the public offering period (or start-up phase) are valued at cost according to the Fair Valuation Committee’s fair valuation methodology unless the REIT issues an updated valuation. The Fund generally purchases REITs at NAV or without a commission. However, startup REITs amortize a significant portion of their start-up costs and therefore, potentially carry additional risks that may impact valuation should the REIT be unable to raise sufficient capital and execute their business plan. As such, start-up REITs pose a greater risk than seasoned REITs because if they encounter going concern issues, they may see significant deviation in value from the fair value, cost basis approach as represented. Non-listed REITs that are in their offering period are generally categorized as Level 3 in the fair value hierarchy. Once a REIT closes to new investors, Management values the security based on the movement of an appropriate market index or a similar security that is publicly traded until the REIT issues an updated market valuation. Non-listed REITs that have closed to new investors are categorized in Level 3 of the fair value hierarchy, due to the significance of the effect of the application of the movement of the market index on the overall fair valuation of the REIT. Other non-traded private investments are monitored for any independent audits of the investment or impairments reported on the potential value of the investment. Certain investments in preferred stocks or private companies are generally categorized as a Level 3 in the fair value hierarchy. The Fund generally values investments in preferred stocks or private companies based on recent transactions and may initially value the investments at cost.

Valuation of Structured Notes — These instruments are notes where the principal and/or interest rate or value of the structured note is determined by reference to the performance of an underlying reference asset. The Fund primarily invests in structured notes that reference the performance of a basket of underlying equity securities. The interest and/or principal payments that may be made on a structured note may vary widely, depending on a variety of factors, including the volatility of the underlying reference asset. The performance results of structured notes will not replicate exactly the performance of the underlying reference asset that the notes seek to replicate due to transaction costs and other expenses. Issuers of structured notes can vary and may include corporations, banks, broker-dealers and limited purpose trusts or other vehicles. Structured notes may be exchange traded or traded OTC and privately negotiated. Structured notes are valued at cost which approximates fair value and monitored for impairment.

Valuation of Alternative Investment Funds — The Fund may invest in funds of open-end or closed-end investment companies (the “Alternative Investment Funds”). The Alternative Investment Funds value securities in their portfolios for which market quotations are readily available at their market values (generally the last reported sale price) and all other securities and assets at their fair value using the methods established by the board of directors of the Alternative Investment Funds. Open-end funds are valued at their NAV and closed-end funds that trade on an exchange are valued as described under security valuation.

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

For Alternative Investment Funds, including private real estate investment trusts, non-traded partnership funds, non-listed business development companies and hedge funds, that are themselves treated as investment companies under GAAP, the Fund follows the guidance in GAAP that allows, as practical expedient, the Fund to value such investments at their reported NAV per share (or if not unitized, at an equivalent percentage of the capital of the investee entity). Such investments typically provide an updated NAV or its equivalent on a quarterly basis. The Fair Valuation Committee meets frequently to discuss the fair valuation methodology and will adjust the value of a security if there is a public update to such valuation.

Non-listed business development companies provide quarterly fair value pricing which is used as an indicator of the valuation for the Fund. If the value significantly fluctuates, the Adviser will provide an updated price. If a significant event occurs that causes a large change in price, the Fair Valuation Committee will call a meeting to evaluate the fair value.

Hedge funds provide monthly fair value pricing which is used as an indicator of the valuation for the Fund. The Fund values the security based on the movement of an appropriate market index or a similar security that is publicly traded until the hedge fund issues an updated market valuation.

ASC 820-10 defines fair value as the price that the Fund would receive to sell an investment or pay to transfer a liability in an orderly transaction with an independent buyer in the principal market, or in the absence of a principal market the most advantageous market for the investment or liability. ASC 820-10 establishes three different categories for valuations. Level 1 valuations are those based upon quoted prices in active markets that the Fund has the ability to access. Level 2 valuations are those based upon quoted prices in inactive markets or based upon significant observable inputs (e.g., yield curves; benchmark interest rates; indices). Level 3 valuations are those based upon unobservable inputs (e.g., discounted cash flow analysis; non-market based methods used to determine fair valuation).

The Fund utilizes various methods to measure the fair value of its investments on a recurring basis. GAAP establishes a hierarchy that prioritizes inputs to valuation methods. The three levels of input are:

●

Level 1 — Unadjusted quoted prices in active markets for identical assets and liabilities that the Fund has the ability to access.

●

Level 2 — Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.

●

Level 3 — Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available; representing the Fund’s own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available.

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3.

The inputs used to measure fair value of a security may fall into different levels (Level 1, Level 2 or Level 3) of the fair value hierarchy. In such cases, for disclosure purposes, the level within which the fair value measurement falls, in its entirety, is determined based on the lowest level input that is significant in its entirety to the fair value measurement.

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following tables summarize the inputs used as of September 30, 2024 for the Fund’s assets and liabilities measured at fair value:

Assets*

	Practical
Investments:	Expedient⁽¹⁾		Level 1		Level 2		Level 3		Total
Common Stocks	$	—	$	16,657,989	$	—	$	—	$	16,657,989
Exchange-Traded Fund		—		3,555,972		—		—		3,555,972
Medium Term Notes		—		—		—		4,000,000		4,000,000
Private Companies		—		—		—		21,280,697		21,280,697
Purchased Options Contracts		—		1,945,545		—		—		1,945,545
Contingent Value Rights		—		—		—		241,226		241,226
Warrants		—		—		—		992,784		992,784
Real Estate Investment Trusts		—		5,519,160		—		19,650,025		25,169,185
Alternative Investment Funds		20,349,958		—		—		22,433,951		42,783,909
Short-Term Investment		—		7,073,430		—		—		7,073,430
Total Investments	$	20,349,958	$	34,752,096	$	—	$	68,598,683	$	123,700,737

Liabilities*

Investments:	Level 1			Level 2		Level 3		Total
Exchange-Traded Fund Sold Short	$	(710,402	)	$	—	$	—	$	(710,402	)
Written Options Contracts		(206,593	)		—		—		(206,593	)
Total Investments	$	(916,995	)	$	—	$	—	$	(916,995	)

⁽¹⁾

Alternative Investment Funds that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Schedule of Investments.

Refer to the Schedule of Investments for industry classifications.

The following is a reconciliation of investments in which significant Level 3 unobservable inputs were used in determining fair value as of September 30, 2024:

Investments	Balance as of March 31, 2024		Transfers into Level 3		Purchase of Investments		Proceeds from Sale of Investments⁽¹⁾			Net Realized Gain (Loss) on Investments		Net Change in Unrealized Appreciation (Depreciation) on Investments			Balance as of September 30, 2024
Contingent Value Rights	$	241,226	$	—	$	—	$	—		$	—	$	—		$	241,226
Warrants		991,088		—		—		—			—		1,696			992,784
Private Companies		16,598,306		—		3,610,969		—			—		1,071,422			21,280,697
Non-Listed Real Estate Investment Trusts		7,266,192		—		—		—			—		800,833			8,067,025
Private Real Estate Investment Trusts		12,555,791		—		—		—			—		(972,791	)		11,583,000
Medium Term Notes		1,500,000		—		4,000,000		(2,590,800	)		1,090,800		—			4,000,000
Alternative Investment Funds		—		23,477,707		—		—			—		(1,043,756	)		22,433,951
Total Investments	$	39,152,603	$	23,477,707	$	7,610,969	$	(2,590,800	)	$	1,090,800	$	(142,596	)	$	68,598,683

⁽¹⁾

Includes return of capital and spin-offs related to corporate actions.

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

The following table summarizes the valuation techniques and significant unobservable inputs used for the Fund’s investments that are categorized in Level 3 of the fair value hierarchy as of September 30, 2024:

Investments

Fair Value
as of
September 30,
2024

Valuation
Techniques

Unobservable
Inputs

Price/
Liquidity
Discount⁽¹⁾

Range of inputs
(average)

Impact on
Valuation
from an
Increase in
Input

Contingent Value Rights

Hospitality Investors Trust, Inc.

241,226

Scenario Analysis

Liquidity Discount/Earnout

0.53

n/a

Ready Capital Corp.

—

Income approach and PWERM Model

Revaluation discount rate/discount rate

0.00

n/a

Decrease

Warrants

Nurture Life, Inc.

992,784

Options Pricing Model and Black-Scholes-Merton Model

Volatility/Risk Free Rate/Years to Exercise Price

n/a

71.8% | 4.0% | 3.0

n/a

Medium Term Notes

Citigroup Global Markets Holdings, Inc.

2,000,000

Other

Transaction Price

100.00

n/a

Increase

Goldman Sachs Finance Corp.

2,000,000

Other

Transaction Price

100.00

n/a

Increase

Private Companies

Always AI, Inc.. Preferred Stock

3,979,042

Comparable public company analysis

Revenue multiples

n/a

3.8x – 14.0x (9.0x)

Increase

Comparable acquisitions analysis

Revenue multiples

n/a

9.5x – 353.8x (140.3x)

Increase

Always AI, Inc.. Convertible Debt

2,600,000

Other

Transaction Price

100.00

n/a

Increase

Clear Street Group Inc.

1,500,002

Other

Transaction Price

8.35

n/a

Increase

Copia Wealth Studios, Common Shares

938,386

Other

Transaction Price

2.82

n/a

Increase

Copia Wealth Studios, Preferred Shares

3,000,000

Other

Transaction Price

2.82

n/a

Increase

Eat Just, Inc.

472,562

Comparable public company analysis

Enterprise Value

n/a

-45.5% - 16.5% (-9.9%)

Increase

Comparable acquisitions analysis

Revenue multiples

n/a

0.4x – 8.0x (2.7x)

Increase

EBITDA multiples

n/a

4.6x – 31.6x (16.8x)

Increase

GOSITE, Inc., Preferred Stock

2,738,373

Comparable public company analysis

Revenue multiples

n/a

2.6x - 15.2x (8.6x)

Increase

EBITDA multiples

n/a

-131.6x - 246.7x (43.3x)

Increase

Comparable acquisitions analysis

Revenue multiples

n/a

0.1x - 7.4x (3.0x)

Increase

EBITDA multiples

n/a

4.3x - 271.7x (29.4x)

Increase

GOSITE, Inc., Convertible Debt

56,331

Other

Transaction Price

100.00

n/a

Increase

Iridia, Inc., Preferred Stock

1,299,458

Other

Transaction Price

2.51

n/a

Increase

Iridia, Inc., Convertible Debt

750,000

Other

Transaction Price

100.00

n/a

Increase

Nurture Life, Inc.

3,946,543

Other

Transaction Price

100.00

n/a

Non-Listed Real Estate Investment Trusts

Healthcare Trust, Inc.

4,937,522

Index Application⁽²⁾

Application of FTSE NAREIT US Health Care Index

228.42

n/a

Increase

NorthStar Healthcare Income, Inc.

3,129,503

Index Application⁽²⁾

Application of FTSE NAREIT US Health Care Index

228.42

n/a

Increase

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

Investments

Fair Value
as of
September 30,
2024

Valuation
Techniques

Unobservable
Inputs

Price/
Liquidity
Discount⁽¹⁾

Range of inputs
(average)

Impact on
Valuation
from an
Increase in
Input

Private Real Estate Investment Trusts

Aventine Property Group, Inc.

6,780,988

Comparable public company analysis

BV Equity multiples

n/a

0.9x - 5.5x (1.8x)

Increase

Comparable acquisitions analysis

BV multiples

n/a

0.9x - 4.5x (2.3x)

Increase

Treehouse Real Estate Investment Trust, Inc.

4,802,012

Comparable public company analysis

BV Equity multiples

n/a

0.9x - 5.5x (1.8x)

Increase

Comparable acquisitions analysis

BV Equity multiples

n/a

0.9x - 4.2x (2.3x)

Increase

Alternative Investment Funds

Canyon CLO Fund II LP

7,911,928

Index Application

Application of CS Leveraged Loan Total Return Index

544.12

n/a

Increase

Canyon CLO Fund III (Cayman) Ltd.⁽³⁾

14,522,023

Index Application

Application of CS Leveraged Loan Total Return Index

544.12

n/a

Increase

Total Investments⁽⁴⁾

68,598,683

	⁽¹⁾	As there was no range for each significant unobservable input, weighted average is not reported.
	⁽²⁾	The Fund utilizes the last publicly stated NAV as published by each Non-Listed REIT, and applies a factor adjustment of the daily publicly available price per each respective index to adjust the price accordingly.
	⁽³⁾	Has an unfunded commitment of $700,000.
	⁽⁴⁾	Certain Level 3 investments of the Fund, totaling fair value assets of $0, have been valued using third-party transactions, quotations, and/or historical information. These assets have been excluded from the preceding table as they are insignificant to the Fund.

BV – book value

The following is the fair value measurement of Alternative Investment Funds that are measured at NAV per share (or its equivalent) as a practical expedient:

Alternative Investment Fund

Investment
Strategy

Value

Unfunded
Commitments

Redemption
Frequency

Redemption
Notice Period

Arboretum Core Asset Fund LP

Debt investing in leased equipment and related financings

2,344,110

—

Annually⁽¹⁾

30 Days⁽¹⁾

Clarion Lion Industrial Trust

Industrial Real Estate

11,087,156

—

Quarterly, subject to advisor discretion

90 Days

Ovation Alternative Income Fund

Private Equity and Private Debt

484,522

—

Quarterly

180 Days

Preservation REIT 1, Inc.

Diversified Direct Real Estate

6,434,170

477,000

Subject to advisor approval

n/a

20,349,958

477,000

⁽¹⁾

Redemptions suspended as of February 28, 2021.

Commitments and Contingencies — The Fund indemnifies the Fund’s officers and the Board for certain liabilities that might arise from their performance of their duties to the Fund. Additionally, in the normal course of business the Fund enters into contracts that contain a variety of representations and warranties and which provide general indemnifications. The Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.

Exchange Traded Funds — The Fund may invest in exchange traded funds (“ETFs”). Most ETFs are a type of index fund bought and sold on a securities exchange. An ETF trades like common stock and represents a fixed (or managed) portfolio of securities designed to track the performance and dividend yield of a particular domestic or foreign market index. The Fund may purchase an ETF to gain exposure to a portion of the U.S. or a foreign market. The risks of owning an ETF generally reflect the risks of owning the underlying securities it is designed to track, although the lack of liquidity in an ETF could result in it being more volatile. Additionally, ETFs have fees and expenses that reduce their value.

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

Restricted securities — Restricted securities are securities that may be resold only upon registration under federal securities laws or in transactions exempt from such registration. In some cases, the issuer of restricted securities has agreed to register such securities for resale, at the issuer’s expense either upon demand by the Fund or in connection with another registered offering of the securities. Many restricted securities may be resold in the secondary market in transactions exempt from registration. Such restricted securities may be determined to be liquid under criteria established by the Board. The restricted securities may be valued at the price provided by dealers in the secondary market or, if no market prices are available, the fair value as determined in good faith using methods approved by the Board. The Alternative Investment Funds generally are restricted securities that are subject to substantial holding periods and are not traded in public markets, so that the Fund may not be able to resell some of its investments for extended periods, which may be several years.

Additional information on each restricted investment held by the Fund at September 30, 2024, is as follows:

Security Description	Acquisition Date	Cost			Value		% of Net Assets
Always AI, Inc., Preferred Stock	1/5/2021	$	1,999,998		$	3,979,042		3.9	%
Always AI, Inc., Convertible Debt	10/2/2023		2,000,000			2,000,000		1.8
Always AI, Inc., Convertible Debt	6/5/2024		600,000			600,000		0.5
Always AI, Inc., Warrants	10/2/2023		—	⁽¹⁾		—		—
Arboretum Core Asset Fund LP	8/2/2018		2,500,000			2,344,110		2.3
Aventine Property Group, Inc.	1/13/2021		5,091,800			6,780,988		6.6
Canyon CLO Fund II LP	2/25/2019		6,132,077			7,911,928		7.7
Canyon CLO Fund III (Cayman) Ltd.	3/1/2022		12,697,773			14,522,023		14.1
Citigroup Global Markets Holdings, Inc.	6/21/2024		2,000,000			2,000,000		1.9
Clarion Lion Industrial Trust	6/29/2015		3,934,581			11,087,156		10.7
Clear Street Group, Inc.	5/11/2022		1,500,000			1,500,002		1.5
Copia Wealth Studios, Common Shares	5/22/2024		333			938,386		0.9
Copia Wealth Studios, Preferred Shares	4/1/2024		3,000,000			3,000,000		2.9
Eat Just, Inc.	6/11/2021		515,501			472,562		0.5
Goldman Sachs Finance Corp.	6/21/2024		2,000,000			2,000,000		1.9
GOSITE, Inc., Preferred Stock	7/31/2020		2,099,998			2,738,373		2.7
GOSITE, Inc., Convertible Debt	11/30/2023		56,331			56,331		0.1
Healthcare Trust, Inc.	3/30/2012		5,151,254			4,937,522		4.8
Hospitality Investors Trust, Inc., Contingent Value Riights	2/17/2015		9,236,371			241,226		0.2
Iridia, Inc., Preferred Stock	2/25/2021		750,000			1,299,458		1.3
Iridia, Inc., Convertible Debt	12/22/2023		750,000			750,000		0.7
NorthStar Healthcare Income, Inc.	3/29/2012		6,706,530			3,129,503		3.0
Nurture Life, Inc., Preferred Stock	8/2/2022		3,257,353			3,946,543		3.8
Nurture Life, Inc., Warrants	12/23/2022		—			992,784		1.0
Ovation Alternative Income Fund	7/25/2014		409,107			484,522		0.5
Preservation REIT 1, Inc.	10/22/2019		3,427,166			6,434,170		6.2
Ready Capital Corp., Contingent Value Rights	7/6/2017		—	⁽¹⁾		—		—
Treehouse Real Estate Investment Trust, Inc.	12/31/2018		8,792,962			4,802,012		4.6
Total		$	84,609,135		$	88,948,641		86.1	%

⁽¹⁾

Transferred at no cost as a result of a corporate action.

Options — The Fund may purchase put and call options on currencies or securities. A put option gives the purchaser the right to compel the writer of the option to purchase from the option holder an underlying currency or security or its equivalent at a specified price at any time during the option period. In contrast, a call option gives the purchaser the right to buy the underlying currency or security covered by the option or its equivalent from the writer of the option at the stated exercise price.

As a holder of a put option, the Fund will have the right to sell the currencies or securities underlying the option and as the holder of a call option, the Fund will have the right to purchase the currencies or securities underlying the option, in each case at their exercise price at any time prior to the option’s expiration date. The Fund may seek to terminate its option positions prior to their expiration by entering into closing transactions. The ability of the Fund to enter into a closing sale transaction depends on the existence of a liquid secondary market. There can be no assurance that a closing

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

purchase or sale transaction can be effected when the Fund so desires. The Fund may close out a position when writing options by purchasing an option on the same security with the same exercise price and expiration date as the option that it has previously written on the security. In such a case, the Fund will realize a profit or loss if the amount paid to purchase an option is less or more than the amount received from the sale of the option.

The hours of trading for options may not conform to the hours during which the underlying securities are traded. To the extent that the options markets close before the markets for the underlying securities, significant price and rate movements can take place in the underlying markets that cannot be reflected in the options markets. The purchase of options is a highly specialized activity which involves investment techniques and risks different from those associated with ordinary portfolio securities transactions. The purchase of options involves the risk that the premium and transaction costs paid by the Fund in purchasing an option will be lost as a result of unanticipated movements in prices of the securities on which the option is based. Imperfect correlation between the options and securities markets may detract from the effectiveness of attempted hedging. Options transactions may result in significantly higher transaction costs and portfolio turnover for the Fund.

Security Transactions and Investment Income — Investment security transactions are accounted for on a trade date basis. Cost is determined and gains and losses are based upon the specific identification method for both financial statement and federal income tax purposes. Dividend income is recorded on the ex-dividend date and interest income is recorded on the accrual basis. Purchase discounts and premiums on securities are accreted and amortized over the life of the respective securities.

Distributions received from investments in securities and private funds that represent a return of capital or capital gains are recorded as a reduction of cost of investment or as a realized gain, respectively. The calendar year-end amounts of ordinary income, capital gains, and return of capital included in distributions received from the Fund’s investments in real estate investment trusts (“REITs”) are reported to the Fund after the end of the calendar year; accordingly, the Fund estimates these amounts for accounting purposes until the characterization of REIT distributions is reported to the Fund after the end of the calendar year. Estimates are based on the most recent REIT distribution information available.

Indemnification — The Fund indemnifies its officers and Trustees for certain liabilities that may arise from the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into contracts that contain a variety of representations and warranties and which provide general indemnities. The Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Trust expects the risk of loss due to these warranties and indemnities to be remote.

3. Investment Management and Other Agreements

The Fund has entered into an investment management agreement (the “Investment Management Agreement”) with the Adviser. Subject to the oversight of the Fund’s Board, the Adviser is responsible for managing the Fund’s business affairs and providing day-to-day administrative services to the Fund either directly or through others selected by it for the Fund.

Pursuant to the Investment Management Agreement dated January 13, 2022, the Adviser is entitled to a management fee, calculated and payable monthly in arrears, at an annual rate of 1.35%, based upon the Fund’s managed assets as of month-end (the “Management Fee”). “Managed Assets” means the total assets of the Fund (including any assets attributable to money borrowed for investment purposes) minus the sum of the Fund’s accrued liabilities (other than money borrowed for investment purposes). Prior to January 13, 2022, under the Fund’s prior investment management agreement, the Adviser was entitled to a management fee, calculated and payable monthly in arrears, at an annual rate of 1.35% of the Fund’s average daily net assets during such period. For the six months ended September 30, 2024, the Adviser earned a Management Fee of $786,794. As of the six months ended September 30, 2024, the Adviser was owed $108,312 in Management Fees, included in payables for Management Fee on the Statement of Assets and Liabilities.

The Fund and Adviser have entered into an investment sub-advisory agreement (the “Sub-Advisory Agreement”) with the Sub-Adviser. Pursuant to the Sub-Advisory Agreement, dated January 13, 2022, the Adviser pays the Sub-Adviser a monthly sub-advisory fee (net of any waivers, reimbursement payments, supermarket fees and alliance fees waived, reimbursed or paid by the Adviser in respect of the Fund) with respect to the assets allocated to the Sub-Adviser (the “Sub-Advised Assets”) equal to 50% of the advisory fee paid to the Adviser for its services to the Fund with respect to the Sub-Advised Assets, equal to a percentage of the Sub-Advised Assets’ average daily managed assets. Prior to January 13, 2022, the Sub-Adviser received a sub-advisory fee at an annual rate equal to 50% of the net Management Fees received by the Adviser after any fee waivers and shared expenses between the Adviser and the Sub-Adviser, subject to a maximum of 0.675% of the Fund’s average daily net assets at month end.

Destra Multi-Alternative Fund

Notes to Financial Statements (continued)

September 30, 2024 (unaudited)

Effective January 13, 2022, the Adviser and the Fund have entered into an expense limitation and reimbursement agreement (the “Expense Limitation Agreement”) under which the Adviser has agreed to reimburse and/or pay or absorb, on a quarterly basis, the “ordinary operating expenses” (as defined below) of the Fund to the extent that such expenses exceed 0.53% per annum of the Fund’s average daily net assets (the “Expense Limitation”). For the purposes of the Expense Limitation Agreement, “ordinary operating expenses” consist of all ordinary expenses of the Fund, including administration fees, transfer agent fees, organization and offering expenses, fees paid to the Fund’s trustees, administrative services expenses, and related costs associated with legal, regulatory compliance and investor relations, but excluding the following: (a) investment management fees, (b) portfolio transaction and other investment-related costs (including brokerage commissions, dealer and underwriter spreads, commitment fees on any leverage facilities, prime broker fees and expenses, and dividend expenses related to short sales), (c) interest expense and other financing costs, (d) taxes, (e) distribution fees and/or shareholder servicing fees, if any, (f) acquired fund fees and expenses and (g) extraordinary expenses. For the six months ended September 30, 2024, the Adviser waived Management Fees of $109,060.

Further, shareholders previously approved, subject to the Fund listing on the NYSE or other national securities exchange, a Secondary Market Support Services Agreement with Destra, whereby the Fund pays Destra a separate 0.10% fee, calculated and paid on Managed Assets, to provide services designed to communicate the investment strategy and investment objective of the Fund to the broader market. Effective March 1, 2022, Destra has voluntarily waived this fee. This voluntary waiver may be revised or terminated at any time without notice. This fee waiver is not subject to recoupment.

Any waiver or reimbursement by the Adviser under the Expense Limitation Agreement is subject to repayment by the Fund within three years from the date the Adviser waived any payment or reimbursed any expense, provided that the Fund is able to make the repayment without exceeding the expense limitation in place at the time of waiver or the current expense limitation and the repayment is approved by the Board. Unless terminated by the Board, the Expense Limitation Agreement will continue in effect until at least January 13, 2027. The Board may terminate this Expense Limitation Agreement upon sixty (60) days’ written notice to the Adviser.

The following amounts are subject to recapture by the Adviser by the following dates:

2/28/2025				3/31/2025				3/31/2026				3/31/2027
$	611,339			$	33,783			$	193,549			$	256,325

4. Investment Transactions

The cost of purchases and proceeds from the sale of securities, other than short-term securities, for the six months ended September 30, 2024, amounted to $31,476,934 and $27,941,795, respectively. The total securities sold short and covered amounted to $61,285 and $1,989,674, respectively.

5. Federal Tax Information

At September 30, 2024, the cost of securities on a tax basis and gross unrealized appreciation and depreciation on investments and securities sold short for federal tax purposes were as follows:

Cost of investments	$	118,345,712
Gross unrealized appreciation		29,816,660
Gross unrealized depreciation